[go: up one dir, main page]

ATE347359T1 - USE OF DEXMEDETOMIDINE FOR SEDATION IN THE ICU - Google Patents

USE OF DEXMEDETOMIDINE FOR SEDATION IN THE ICU

Info

Publication number
ATE347359T1
ATE347359T1 AT99913332T AT99913332T ATE347359T1 AT E347359 T1 ATE347359 T1 AT E347359T1 AT 99913332 T AT99913332 T AT 99913332T AT 99913332 T AT99913332 T AT 99913332T AT E347359 T1 ATE347359 T1 AT E347359T1
Authority
AT
Austria
Prior art keywords
dexmedetomidine
icu
sedation
Prior art date
Application number
AT99913332T
Other languages
German (de)
Inventor
Riku Aantaa
Romeo Bachand
Esa Heinonen
Original Assignee
Orion Corp
Hospira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26763325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE347359(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp, Hospira Inc filed Critical Orion Corp
Application granted granted Critical
Publication of ATE347359T1 publication Critical patent/ATE347359T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99913332T 1998-04-01 1999-03-31 USE OF DEXMEDETOMIDINE FOR SEDATION IN THE ICU ATE347359T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8028798P 1998-04-01 1998-04-01
US11094498P 1998-12-04 1998-12-04

Publications (1)

Publication Number Publication Date
ATE347359T1 true ATE347359T1 (en) 2006-12-15

Family

ID=26763325

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99913332T ATE347359T1 (en) 1998-04-01 1999-03-31 USE OF DEXMEDETOMIDINE FOR SEDATION IN THE ICU

Country Status (27)

Country Link
EP (1) EP1069893B1 (en)
JP (1) JP4606581B2 (en)
KR (1) KR20010034728A (en)
CN (1) CN1168441C (en)
AR (1) AR015744A1 (en)
AT (1) ATE347359T1 (en)
AU (1) AU754484B2 (en)
BG (1) BG64540B1 (en)
BR (1) BR9909872A (en)
CA (1) CA2326339C (en)
CZ (1) CZ301013B6 (en)
DE (1) DE69934305T2 (en)
DK (1) DK1069893T3 (en)
EA (1) EA005524B1 (en)
ES (1) ES2278441T3 (en)
GB (1) GB2352972B (en)
HU (1) HU229162B1 (en)
IL (1) IL138416A (en)
NO (1) NO329194B1 (en)
NZ (1) NZ507203A (en)
PL (1) PL192517B1 (en)
PT (1) PT1069893E (en)
SI (1) SI1069893T1 (en)
SK (1) SK286160B6 (en)
TR (1) TR200002837T2 (en)
TW (1) TW552136B (en)
WO (1) WO1999049854A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1223931B1 (en) 1999-10-29 2005-12-14 Orion Corporation Use of a imidazole derivative for the treatment or prevention of hypotension and shock
KR20070087004A (en) * 2002-04-08 2007-08-27 엠쥐아이 쥐피, 아이엔씨. Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering the same
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
US20060058700A1 (en) * 2004-08-26 2006-03-16 Marro Dominic P Patient sedation monitor
ES2573253T3 (en) 2006-09-20 2016-06-06 The Board Of Regents Of The University Of Texas System Methods for the supply of volatile anesthetics for regional anesthesia and / or pain relief
CN107661293A (en) 2008-01-22 2018-02-06 得克萨斯大学体系董事会 The volatile anesthetic composition containing extractant for local anaesthesia and/or pain relief
NZ596976A (en) * 2009-05-15 2014-05-30 Recro Pharma Inc Sublingual dexmedetomidine compositions and methods of use thereof
DE102009050016A1 (en) 2009-05-27 2011-05-05 Modine Manufacturing Co., Racine Heat exchanger unit
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
JP6268100B2 (en) 2011-12-11 2018-01-24 レクロ・ファーマ，インコーポレーテッド Intranasal dexmedetomidine composition and method of use thereof
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
JP5921928B2 (en) * 2012-03-28 2016-05-24 テルモ株式会社 Already diluted dexmedetomidine preparation
CN104797252B (en) * 2012-10-15 2016-09-21 奥赖恩公司 Alleviate the veterinary methods that noise is detested
KR101831536B1 (en) 2013-07-24 2018-04-04 아이-테크 에이비 Use of the enantiomer levomedetomidine as inhibitor for marine biofouling of surfaces
KR20180095732A (en) 2013-10-07 2018-08-27 테이코쿠 팔마 유에스에이, 인코포레이티드 Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
CA2924231C (en) 2013-10-07 2018-04-03 Teikoku Pharma Usa, Inc. Dexmedetomidine transdermal delivery devices and methods for using the same
CN106456561B (en) * 2013-10-07 2020-02-28 帝国制药美国公司 Methods and compositions for treating ADHD, anxiety, and insomnia using dexmedetomidine transdermal compositions
CN113975273B (en) * 2020-07-27 2023-07-11 宜昌人福药业有限责任公司 Nanometer suspension nasal spray for resisting anxiety and preparation method thereof
CN115197148B (en) * 2021-04-02 2023-12-12 四川大学华西医院 A kind of 5-benzyl imidazole compound and preparation method and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (en) * 1984-12-04 1984-12-04 Farmos Oy TERAPEUTISKT UTNYTTJBAR FOERENING.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (en) * 1989-10-17 1989-10-17 Farmos Oy EN TERAPEUTISKT VAERDEFULL FOERENING.
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine

Also Published As

Publication number Publication date
CA2326339A1 (en) 1999-10-07
EP1069893A2 (en) 2001-01-24
EA005524B1 (en) 2005-04-28
ES2278441T3 (en) 2007-08-01
JP2002509880A (en) 2002-04-02
BG64540B1 (en) 2005-07-29
TW552136B (en) 2003-09-11
CN1295473A (en) 2001-05-16
CZ20003484A3 (en) 2002-01-16
BR9909872A (en) 2007-11-20
WO1999049854A2 (en) 1999-10-07
CN1168441C (en) 2004-09-29
AR015744A1 (en) 2001-05-16
HUP0101498A3 (en) 2002-06-28
TR200002837T2 (en) 2001-01-22
BG104797A (en) 2001-07-31
HU229162B1 (en) 2013-09-30
IL138416A0 (en) 2001-10-31
JP4606581B2 (en) 2011-01-05
GB2352972A (en) 2001-02-14
HUP0101498A1 (en) 2002-03-28
PL192517B1 (en) 2006-10-31
AU3149499A (en) 1999-10-18
CZ301013B6 (en) 2009-10-14
PT1069893E (en) 2007-01-31
NZ507203A (en) 2003-03-28
KR20010034728A (en) 2001-04-25
CA2326339C (en) 2008-12-23
NO20004931L (en) 2000-09-29
DK1069893T3 (en) 2007-03-19
NO20004931D0 (en) 2000-09-29
EA200001010A1 (en) 2001-02-26
NO329194B1 (en) 2010-09-13
GB2352972B (en) 2003-05-21
EP1069893B1 (en) 2006-12-06
AU754484B2 (en) 2002-11-14
IL138416A (en) 2005-07-25
SK14362000A3 (en) 2002-03-05
GB0024932D0 (en) 2000-11-29
SI1069893T1 (en) 2007-04-30
DE69934305T2 (en) 2007-07-12
PL343553A1 (en) 2001-08-27
DE69934305D1 (en) 2007-01-18
SK286160B6 (en) 2008-04-07
WO1999049854A3 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
ATE347359T1 (en) USE OF DEXMEDETOMIDINE FOR SEDATION IN THE ICU
ATE288424T1 (en) DIAMINOTHIAZOLES AND THEIR USE FOR INHIBITING PROTEIN KINASES
DE60000958D1 (en) Epoxy resin composition and its use
DE69903655D1 (en) USE OF MENTHYL-2-PYRROLIDONE-5-CARBOXYLATE FOR INSECT REVENTION
DE60027479D1 (en) RESIN STRUCTURE AND ITS USE
DE60204533D1 (en) Use of inkjet inks with reduced corrosion
DE69739892D1 (en) Use of pearled food additives
DE59905858D1 (en) USE OF PIT EMULSIONS
DE60121609D1 (en) MODIFIED POLYOLEFIN RESIN, MODIFIED POLYOLEFIN RESIN COMPOSITION AND ITS USE
ATE251892T1 (en) FOAMING OIL COMPOSITION AND USE THEREOF
DE50212455D1 (en) Use of dimerdiols
DE60300191T8 (en) Communication terminal for restricting the use of content
DE50106899D1 (en) Y-REINFORCEMENT FOR INCREASING THE BENDING AND TORSION STIFFNESS OF RAW BODIES
DE69719137D1 (en) Use of surface-active additives in the direct production of trialkoxysilanes
DE60021903D1 (en) USE OF COMPOSITIONS FOR TEXTILE CARE
DE60034106D1 (en) Aqueous emulsion polymerization compositions and their use for paper lamination
DE69620914D1 (en) PERFLUORALKOXYCYCLOALKANCARBONYLFLUORID COMPOSITIONS AND THEIR USE
DE69806419D1 (en) Resin composition and its use
DE50008549D1 (en) TRIAZOLOTRIAZINONE AND THEIR USE
DE69915486D1 (en) USE OF ELETRIPTAN TO PREVENT THE RECURRENCE OF MIGRAINE
DE50202730D1 (en) SUBSTITUTED ISOINDOLE AND ITS USE
DE60030366D1 (en) Flexible resin composition and its use
DE69914107D1 (en) SENSOR FOR EVALUATING THE DIELECTRICAL PROPERTIES OF SPECIAL PAPER
DE50311406D1 (en) Use of moldings
DE60101245D1 (en) Coating composition and its use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1069893

Country of ref document: EP